Related Experiment Videos

Analogs of farnesylcysteine induce apoptosis in HL-60 cells

D Pérez-Sala1, B A Gilbert, R R Rando

  • 1Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, C.S.I.C., Madrid, Spain. lperezsala@fresno.csic.es

FEBS Letters
|May 26, 1998
PubMed

Insights

S-Farnesyl-thioacetic acid (FTA) effectively inhibited cancer cell growth and induced apoptosis. However, this effect was independent of ras protein changes, suggesting alternative mechanisms for farnesylcysteine analog-induced cell death.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Isoprenylated protein methyltransferase is a target for cancer therapeutics.
  • S-Farnesyl-thioacetic acid (FTA) is a known inhibitor of this enzyme.
  • Ras proteins are key signaling molecules involved in cell growth and survival.

Purpose of the Study:

  • To investigate the mechanism by which FTA suppresses cancer cell growth and induces apoptosis.
  • To determine the role of ras protein prenylation and membrane association in FTA-induced apoptosis.

Main Methods:

  • HL-60 cell line was treated with FTA.
  • Apoptosis was assessed using annexin-V binding, DNA dye exclusion, and DNA laddering assays.
  • Ras protein localization (cytosolic vs. membrane-associated) was analyzed via Western blotting.

Main Results:

  • FTA potently suppressed HL-60 cell growth and induced apoptosis.
  • FTA treatment did not affect the membrane association of ras proteins.
  • FTA decreased the proportion of cytosolic ras, indicating a shift in its localization.
  • Weak methyltransferase inhibitors also induced apoptosis and altered ras localization.

Conclusions:

  • Inhibition of isoprenylated protein methylation is not essential for FTA-induced apoptosis.
  • Impairment of ras membrane association is not required for apoptosis induced by farnesylcysteine analogs.
  • The study suggests alternative pathways mediating the apoptotic effects of these compounds.

Related Concept Videos